Histamine-releasing factors, a heterogeneous group of different activities

Clinical and Experimental Allergy

Volumn 33, Issue 9, 2003, Pages 1175-1182

  Kleine Budde, Ilona ^a   Aalberse, R C ^b  

^a SANQUIN RESEARCH   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 1; INTERLEUKIN 3; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN; PROTEIN P23; RANTES;

ALLERGIC DISEASE; ALLERGIC REACTION; ANTIGEN BINDING; ASTHMA; AUTOIMMUNITY; BASOPHIL; CROSS REACTION; HISTAMINE RELEASE; HUMAN; MONONUCLEAR CELL; PRIORITY JOURNAL; REVIEW;

ALLERGENS; ASTHMA; BASOPHILS; CROSS REACTIONS; GLYCOSYLATION; HISTAMINE RELEASE; HUMANS; HYPERSENSITIVITY; IMMUNIZATION; POACEAE; POLLEN; RECEPTORS, IGE; TUMOR MARKERS, BIOLOGICAL;

EID: 0042235617     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2003.01767.x     Document Type: Review

References (78)

1. Thueson DO, Speck LS, Lett-Brown MA, Grant JA. Histamine-releasing activity (HRA). 1. Production by mitogen-or antigen-stimulated human mononuclear cells. J Immunol 1979; 123:626-32.
2. Lett-Brown MA, Thueson DO, Plank DE, Duffy L, Grant JA. Histamine-releasing activity. V. Characterization and purification using high-performance liquid chromatography. Cell Immunol 1984; 87:445-51.
3. Alam R, Forsythe PA, Lett-Brown MA, Grant JA. Cellular origin of histamine-releasing factor produced by peripheral blood mononuclear cells. J Immunol 1989; 142:3951-6.
4. Schulman ES, Liu MC, Proud D, MacGlashan DWJ, Lichtenstein LM, Plaut M. Human lung macrophages induce histamine release from basophils and mast cells. Am Rev Respir Dis 1985; 131:230-5.
5. Orchard MA, Kagey-Sobotka A, Proud D, Lichtenstein LM. Basophil histamine release induced by a substance from stimulated human platelets. J Immunol 1986; 136:2240-4.
6. White JM, Kaliner MA. Neutrophils and mast cells. I. Human neutrophil-derived histamine-releasing activity. J Immunol 1987; 139:1624-30.
7. Baeza ML, Haak-Frendscho M, Satnick S, Kaplan AP. Responsiveness to human mononuclear cell-derived histamine-releasing factor. Studies of allergic status and the role of IgE. J Immunol 1988; 141:2688-92.
8. Liu MC, Proud D, Lichtenstein LM et al. Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors. J Immunol 1986; 136:2588-95.
9. Lichtenstein LM. Histamine-releasing factors and IgE heterogeneity. J Allergy Clin Immunol 1988; 81:814-9.
10. Ezeamuzie IC, Assem ES. Antigen-induced formation of a lymphokine with a possible role as a mediator of the late component of dual allergic reaction. Int Arch Allergy Appl Immunol 1987; 82:221-4.
11. Warner JA, Pienkowski MM, Norman Plaut M, Lichtenstein LM. Identification of histamine releasing factor(s) in the late phase of cutaneous IgE-mediated reactions. J Immunol 1986; 136:2583-7.
12. MacDonald SM, Lichtenstein LM, Proud D et al. Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol 1987; 139:506-12.
13. Pasmans SGMA, Aalbers M, Daha MR, Knol EF, Jansen HM, Aalberse RC. Histamine-releasing activity in supernatants of mononuclear cells: contribution of monocyte chemotactic protein-1 activity compared with IgE-dependent activity. J Allergy Clin Immunol 1996; 98:962-8.
14. MacDonald SM, Rafnar T, Langdon J, Lichtenstein LM. Molecular identification of an IgE-dependent histamine-releasing factor. Science 1995; 269:688-90.
15. Vonakis BM, Gibbons S Jr, Sora R., Langdon JM, MacDonald SM. Src homology 2 domain-containing inositol 5′ phosphatase is negatively associated with histamine release to human recombinant histamine- releasing factor in human basophils. J Allergy Clin Immunol 2001; 108:822-31.
16. Valenta R, Maurer D, Steiner R et al. Immunoglobulin E response to human proteins in atopic patients. J Invest Dermatol 1996; 107:203-8.
17. Crameri R, Faith A, Hemmann S et al. Humoral and cell-mediated autoimmunity in allergy to Aspergillus fumigatus. J Exp Med 1996; 184:265-70.
18. Haak-Frendscho M, Sarafi M, Delespesse G, Kaplan AP. Comparison of mononuclear cells and B-lymphoblastoid histamine-releasing factor and their distinction from an IgE-binding factor. Clin Immunol Immunopath 1988; 49:72-82.
19. Robertson MW, Albrandt K, Keller D, Liu FT. Human IgE-binding protein: a soluble lectin exhibiting a highly conserved interspecies sequence and differential recognition of IgE glycoforms. Biochemistry 1990; 29:8093-100.
20. Kuna P, Reddigari SR, Rucinski D, Oppenheim JJ, Kaplan AP. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J Exp Med 1992; 175:489-93.
21. Alam R, Lett-Brown MA, Forsythe PA et al. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils. J Clin Invest 1992; 89:723-8.
22. Bischoff SC, Krieger M, Brunner T, Dahinden CA. Monocyte chemotactic protein 1 is a potent activator of human basophils. J Exp Med 1992; 175:1271-5.
23. Dahinden CA, Geiser T, Brunner T et al. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J Exp Med 1994; 179:751-6.
24. Stellato C, Collins P, Ponath PD et al. Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J Clin Invest 1997; 99:926-36.
25. Kuna P, Reddigari SR, Schall TJ, Rucinski D, Viksman MY, Kaplan AP. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J Immunol 1992; 149:636-42.
26. Alam R, Forsythe PA, Stafford S, Lett-Brown MA, Grant JA. Macrophage inflammatory protein-1 α activates basophils and mast cells. J Exp Med 1992; 176:781-6.
27. Forssmann U, Uguccioni M, Loetscher P et al. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med 1997; 185:2171-6.
28. Subramanian N, Bray MA. Interleukin 1 releases histamine from human basophils and mast cells in vitro. J Immunol 1987; 138:271-5.
29. Haak-Frendscho M, Dinarello C, Kaplan AP. Recombinant human interleukin-1 beta causes histamine release from human basophils. J Allergy Clin Immunol 1988; 82:218-23.
30. MacDonald SM, Schleimer RP, Kagey-Sobotka A, Gillis S, Lichtenstein LM. Recombinant IL-3 induces histamine release from human basophils. J Immunol 1989; 142:3527-32.
31. Haak-Frendscho M, Arai N, Arai K, Baeza ML, Finn A, Kaplan AP. Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release. J Clin Invest 1988; 82:17-20.
32. Massey WA, Randall TC, Kagey-Sobotka A et al. Recombinant human IL-1a and -1b potentiate IgE-mediated histamine release from human basophils. J Immunol 1989; 143:1875-80.
33. Hirai K, Morita Y, Misaki Y et al. Modulation of human basophil histamine release by hemopoietic growth factors. J Immunol 1988; 141:3958-64.
34. Pasmans SGMA, Witteman AM, Aalbers M et al. Variability of IgE-dependent activity in supernatants of human mononuclear cells. Int Arch Allergy Immunol 1994; 103:44-52.
35. Marone G, Casolaro V, Paganelli R, Quinti I. IgG anti-IgE from atopic dermatitis induces mediator release from basophils and mast cells. J Invest Dermatol 1989; 93:246-52.
36. Marone G, Spadaro G, Palumbo C, Condorelli G. The anti-IgE/anti-Fcε RIα autoantibody network in allergic and autoimmune diseases. Clin Exp Allergy 1999; 29:17-27.
37. Shakib F, Smith SJ. In vitro basophil histamine-releasing activity of circulating IgG1 and IgG4 autoanti-IgE antibodies from asthma patients and the demonstration that anti-IgE modulates allergen-induced basophil activation. Clin Exp Allergy 1994; 24:270-5.
38. MacDonald SM, Lichtenstein LM. Histamine-releasing factors and heterogeneity of IgE. Springer Semin Immunopathol 1990; 12:415-28.
39. Kleine-Tebbe J, Kagey-Sobotka A, MacGlashan DW, Lichtenstein LM, MacDonald SM. Lectins do not distinguish between heterogenous IgE molecules as defined by differential activity of an IgE-dependent histamine releasing factor. J Allergy Clin Immunol 1996; 98:181-8.
40. Shibasaki M, Sumazaki R, Isoyama S, Takita H. Interaction of lectins with human IgE: IgE-binding property and histamine-releasing activity of twelve plant lectins. Int Arch Allergy Immunol 1992; 98:18-25.
41. Lyczak JB, Zhang K, Saxon A, Morrison SL. Expression of novel secreted isoforms of human immunoglobulin E proteins. J Biol Chem 1996; 271:3428-36.
42. Batista FD, Efremov DG, Burrone OR. Characterization of a second secreted IgE isoform and identification of an asymmetric pathway of IgE assembly. Proc Natl Acad Sci USA 1996; 93:3399-404.
43. Hellman L. Characterization of four novel ε chain mRNA and a comparative analysis of genes for immunoglobulin E in rodents and man. Eur J Immunol 1993; 23:159-67.
44. Chan LA, Lyczak JB, Zhang K, Morrison SL, Saxon A. The novel human IgE ε heavy chain, ε tailpiece, is present in plasma as part of a covalent complex. Mol Immunol 2000; 37:241-52.
45. Kleine Budde I., Knol EF, Aalbers M, van der Zee JS, Aalberse RC. Reactivity to IgE-dependent histamine-releasing factor is due to monomeric IgE. Allergy 2000; 55:653-7.
46. Johansson SG, Inganas M. Interaction of polyclonal human IgE with protein-A from Staphylococcus aureus. Immunol Rev 1978; 41:248-60.
47. Schroeder JT, Lichtenstein LM, MacDonald SM. Recombinant histamine-releasing factor enhances IgE-dependent IL-4 and IL-13 secretion by human basophils. J Immunol 1997; 159:447-52.
48. Bischoff SC, de Weck AL, Dahinden CA. Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a. Proc Natl Acad Sci U S A 1990; 87:6813-7.
49. Bischoff SC, Brunner T, de Weck AL, Dahinden CA. Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J Exp Med 1990; 172:1577-82.
50. Gross B, Gaestel M, Bohm H, Bielka H. cDNA sequence coding for a translationally controlled human tumor protein. Nucleic Acids Res 1989; 17:8367.
51. MacDonald SM. Histamine-releasing factors. Curr Opin Immunol 1996; 8:778-83.
52. Wantke F, MacGlashan DW, Langdon JM, MacDonald SM. The human recombinant histamine releasing factor: functional evidence that it does not bind to the IgE molecule. J Allergy Clin Immunol 1999; 103:642-8.
53. Bheekha-Escura R, Chance SR, Langdon JM, MacGlashan DWJ, MacDonald SM. Pharmacologic regulation of histamine release by the human recombinant histamine-releasing factor. J Allergy Clin Immunol 1999; 103:937-43.
54. Kleine Budde I, Lopuhaa CE, de Heer PG et al. Lack of correlation between bronchial late allergic reaction to Dermatophagoides pteronyssinus and in vitro Immunoglobulin E reactivity to histamine-releasing factor derived from mononuclear cells. Ann Allergy Asthma Immunol 2002; 89:606-12.
55. Bheekha-Escura R, MacGlashan DW, Langdon JM, MacDonald SM. The human recombinant histamine releasing factor (HrHRF) activates human eosinophils and the eosinophilic-like cell line, AML 14-3D10. Blood 2000; 96:2191-8.
56. Valenta R, Duchene M, Pettenburger K. et al. Identification of profilin as a novel pollen allergen; IgE autoreactivity in sensitized individuals. Science 1991; 253:557-60.
57. Fluckiger S, Fijten H, Whitley P, Blaser K, Crameri R. Cyclophilins, a new family of cross-reactive allergens. Eur J Immunol 2002; 32:10-7.
58. Mayer C, Hemmann S, Faith A, Blaser K, Crameri R. Cloning, production, characterization and IgE cross-reactivity of different manganese superoxide dismutases in individuals sensitized to Aspergillus fumigatus. Int Arch Allergy Immunol 1997; 113:213-5.
59. Natter S, Seiberler S, Hufnagl P et al. Isolation of cDNA clones coding for IgE autoantigens with serum IgE from atopic dermatitis patients. FASEB J 1998; 12:1559-69.
60. Kleine Budde I, de Heer PG, Natter S. Studies on the association between IgE autoreactivity and IgE-dependent histamine-releasing factors. Immunology 2002; 107:243-51.
61. Pasmans SGMA, Aalbers M, van der Veen MJ et al. Reactivity to IgE-dependent histamine-releasing activity in asthma or rhinitis. Am J Respir Crit Care Med 1996; 154:318-23.
62. van Ree R, Voitenko V, van Leeuwen WA, Aalberse RC. Profilin is a cross-reactive allergen in pollen and vegetable foods. Int Arch Allergy Immunol 1992; 98:97-104.
63. Miadonna A, Roncarolo MG, Lorini M, Tedeschi A. Inducing and enhancing effects of IL-3,-5, and -6 and GM-CSF on histamine release from human basophils. Clin Immunol Immunopath 1993; 67:210-5.
64. MacGlashan DWJ, Schleimer RP, Peters SP et al. Comparative studies of human basophils and mast cells. Fed Proc 1983; 42:2504-9.
65. Busse WW, Calhoun WF, Sedgwick JD. Mechanism of airway inflammation in asthma. Am Rev Respir Dis 1993; 147:S20-S24.
66. Bascom R, Pipkorn U, Lichtenstein LM, Naclerio RM. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment. Am Rev Respir Dis 1988; 138:406-12.
67. De Monchy JG, Kauffman HF, Venge P et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985; 131:373-6.
68. Liu MC, Hubbard WC, Proud D et al. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. Am Rev Respir Dis 1991; 144:51-8.
69. Charlesworth EN, Hood AF, Soter NA, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. J Clin Invest 1989; 83:1519-26.
70. Schleimer RP, Fox CC, Naclerio RM et al. Role of human basophils and mast cells in the pathogenesis of allergic diseases. J Allergy Clin Immunol 1985; 76:369-74.
71. Guo CB, Liu MC, Galli SJ, Bochner BS, Kagey-Sobotka A, Lichtenstein LM. Identification of IgE-bearing cells in the late-phase response to antigen in the lung as basophils. Am J Respir Cell Mol Biol 1994; 10:384-90.
72. Naclerio RM, Hubbard W, Lichtenstein LM, Kagey-Sobotka A, Proud D. Origin of late phase histamine release. J Allergy Clin Immunol 1996; 98:721-3.
73. Charlesworth EN, Iliopoulos O, MacDonald SM, Kagey-Sobotka A, Lichtenstein LM. Cells and secretagogous involved in human late-phase response. Int Arch Allergy Appl Immunol 1989; 88:50-3.
74. Gounni AS, Lamkhioued B, Ochiai K et al. High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 1994; 367:183-6.
75. Dombrowicz D, Woerly G, Capron M. IgE receptors on human eosinophils. Chem Immunol 2000; 76:63-76.
76. Maurer D, Fiebiger E, Reininger B et al. Expression of functional high affinity immunoglobulin E receptors (Fc ε RI) on monocytes of atopic individuals. J Exp Med 1994; 179:745-50.
77. Maurer D, Ebner C, Reininger B et al. The high affinity IgE receptor (Fc ε RI) mediates IgE-dependent allergen presentation. J Immunol 1995; 154:6285-90.
78. MacDonald SM. Human recombinant histamine-releasing factor. Int Arch Allergy Immunol 1997; 113:187-9.